Cargando…
Targeting Cytotoxic Agents through EGFR-Mediated Covalent Binding and Release
[Image: see text] A major drawback of cytotoxic chemotherapy is the lack of selectivity toward noncancerous cells. The targeted delivery of cytotoxic drugs to tumor cells is a longstanding goal in cancer research. We proposed that covalent inhibitors could be adapted to deliver cytotoxic agents, con...
Autores principales: | Morese, Pasquale A., Anthony, Nahoum, Bodnarchuk, Michael, Jennings, Claire, Martin, Mathew P., Noble, Richard A., Phillips, Nicole, Thomas, Huw D., Wang, Lan Z., Lister, Andrew, Noble, Martin E. M., Ward, Richard A., Wedge, Stephen R., Stewart, Hannah L., Waring, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510387/ https://www.ncbi.nlm.nih.gov/pubmed/37647129 http://dx.doi.org/10.1021/acs.jmedchem.3c00845 |
Ejemplares similares
-
Modulation
of ERK5 Activity as a Therapeutic Anti-Cancer
Strategy
por: Miller, Duncan C., et al.
Publicado: (2023) -
Fragment expansion with NUDELs – poised DNA-encoded libraries
por: Salvini, Catherine L. A., et al.
Publicado: (2023) -
Parallel Optimization
of Potency and Pharmacokinetics
Leading to the Discovery of a Pyrrole Carboxamide ERK5 Kinase Domain
Inhibitor
por: Miller, Duncan C., et al.
Publicado: (2022) -
Characterization of Covalent-Reversible EGFR Inhibitors
por: Smith, Steven, et al.
Publicado: (2017) -
Simultaneous targeting of glycolysis and oxidative phosphorylation as a therapeutic strategy to treat diffuse large B-cell lymphoma
por: Noble, Richard A., et al.
Publicado: (2022)